Skip to main content
FinSpry Logo
FinSpry
IBRX logo
IBRX
(NASDAQ)
ImmunityBio, Inc.
$7.30-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

ImmunityBio (IBRX) Stock Price & Financial Analysis

ImmunityBio Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$6.88 - $7.35
52-Week High$12.43
52-Week Low$1.83
Open$6.89
Volume14.17M
Average Volume (3M)14.17M
Market Cap6.71B
Shares Outstanding919.86M
Price to Sales (P/S)57.97
EV/EBITDA-32.91
Revenue (TTM)113.29M
Net Income (TTM)-351.40M
Free Cash Flow (TTM)-308.78M
EPS (TTM)$-0.36
Profit Margin-310.18%
Operating Margin-226.00%
50-Day MA$7.75
200-Day MA$3.81
52-Week Change141.22%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About ImmunityBio

What is the current stock price for IBRX?

As of the latest trading session, IBRX stock trades at $7.30. The 52-week range is $1.83–$12.43, with a day range of $6.88–$7.35.

What is the P/E ratio for IBRX?

The P/E ratio (Price-to-Earnings) for IBRX is shown in the Key Statistics section. This valuation metric helps compare ImmunityBio, Inc. to industry peers.

Does IBRX pay dividends?

ImmunityBio does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IBRX?

Based on 6 analysts, the consensus for IBRX is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of IBRX?

ImmunityBio's market capitalization is $6.71B, classifying it as a mid-cap company. ImmunityBio operates in the Healthcare sector within the Biotechnology industry.